At a glance
ClinicalIndex Comparison RecordN/ACompleted· 154 enrolled
Drug / intervention
Inverse/Reverse Shoulder Arthroplastyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Anatomical Shoulder™ Inverse/Reverse Post-Market Surveillance Study
In Brief
A clinical study evaluating Inverse/Reverse Shoulder Arthroplasty for Cuff-tear Arthropathy. Completed, enrolled 154 participants across 5 sites in 4 countries.
Detailed Summary
The purpose of this study is to obtain outcomes data on the Anatomical Shoulder™ Inverse/Reverse System by analysis of standard scoring systems and radiographs. Outcome data will be collected using the following standard scoring systems of which summary statistics will be provided: • Constant and Murley Score to evaluate clinical parameters such as range of motion, power, level of pain and functional ability.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCuff-tear Arthropathy
CountriesBelgium, Germany, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2007
First PostedJun 2015
Primary CompletionFeb 2022
Study CompletionMar 2024
TodayJul 2026
First PostedJun 9, 2015
Enrollment StartMay 16, 2007
Primary CompletionFeb 16, 2022
Study CompletionMar 11, 2024
TodayJul 2, 2026
Enrollment to primary: 14.8 yearsPosted 11.1 years ago
Interventions
Inverse/Reverse Shoulder Arthroplastyprocedure
Implantation of the Anatomical Shoulder Inverse/Reverse System